Di Febo, Riccardo
Saeed, Zeeba
Serafini, Francesco
Brocco, Davide
D’Ascanio, Francesca
Pizzi, Andrea Delli
Tinari, Nicola
Crescitelli, Rossella
Lanuti, Paola
Renda, Giulia https://orcid.org/0000-0002-4770-8386
Article History
Received: 31 January 2025
Accepted: 22 April 2025
First Online: 16 May 2025
Declarations
:
: Not applicable (review).
: Not applicable (review).
: RC has developed multiple EV-associated patents for putative clinical utilization: US20200088734 A1, United States; WO2020146390 A1, WIPO (PCT). RC owns equity in Exocure Bioscience Inc. The other authors declare that they have no competing interests.